Olaparib targets Ubiquitin D to promote autophagy in hepatocellular carcinoma by regulating glutamine metabolism.
[BACKGROUND] To explore Ubiquitin D (UBD) and autophagy in hepatocellular carcinoma (HCC) and the key role of Olaparib targeting UBD in treating HCC.
APA
Zhu W, Zhang F, et al. (2026). Olaparib targets Ubiquitin D to promote autophagy in hepatocellular carcinoma by regulating glutamine metabolism.. Expert review of anticancer therapy, 26(3), 385-394. https://doi.org/10.1080/14737140.2025.2586736
MLA
Zhu W, et al.. "Olaparib targets Ubiquitin D to promote autophagy in hepatocellular carcinoma by regulating glutamine metabolism.." Expert review of anticancer therapy, vol. 26, no. 3, 2026, pp. 385-394.
PMID
41195548
Abstract
[BACKGROUND] To explore Ubiquitin D (UBD) and autophagy in hepatocellular carcinoma (HCC) and the key role of Olaparib targeting UBD in treating HCC.
[RESEARCH DESIGN AND METHODS] Bioinformatics analysis was conducted to study UBD expression in HCC tissues. qRT-PCR and Western blot measured UBD mRNA/protein levels, autophagy markers, and Gln metabolism proteins in HCC tissues. Cellular thermal shift assay (CETSA) confirmed Olaparib-UBD interaction. A xenograft tumor model was established to observe tumor growth in mice, with qRT-PCR and western blot used to measure UBD expression levels in tumor tissues and Immunohistochemistry (IHC) used to assess expression of Microtubule-associated protein light chain 3 (LC3), sequestosome 1 (P62), solute carrier family 1 member 5 (SLC1A5), and glutaminase (GLS).
[RESULTS] UBD was highly expressed in HCC tissues ( = 7.6e-11). UBD could negatively regulate autophagy levels by activating Gln metabolism. Olaparib could target and downregulate UBD expression, promoting HCC cell autophagy by regulating Gln metabolism pathways. Olaparib treatment in xenograft mice overexpressing UBD significantly reduced tumor growth ( < 0.05), inhibited Gln metabolism pathways, and enhanced HCC cell autophagy.
[CONCLUSIONS] Olaparib targeted UBD to promote autophagy in HCC by inhibiting Gln metabolism pathways.
[RESEARCH DESIGN AND METHODS] Bioinformatics analysis was conducted to study UBD expression in HCC tissues. qRT-PCR and Western blot measured UBD mRNA/protein levels, autophagy markers, and Gln metabolism proteins in HCC tissues. Cellular thermal shift assay (CETSA) confirmed Olaparib-UBD interaction. A xenograft tumor model was established to observe tumor growth in mice, with qRT-PCR and western blot used to measure UBD expression levels in tumor tissues and Immunohistochemistry (IHC) used to assess expression of Microtubule-associated protein light chain 3 (LC3), sequestosome 1 (P62), solute carrier family 1 member 5 (SLC1A5), and glutaminase (GLS).
[RESULTS] UBD was highly expressed in HCC tissues ( = 7.6e-11). UBD could negatively regulate autophagy levels by activating Gln metabolism. Olaparib could target and downregulate UBD expression, promoting HCC cell autophagy by regulating Gln metabolism pathways. Olaparib treatment in xenograft mice overexpressing UBD significantly reduced tumor growth ( < 0.05), inhibited Gln metabolism pathways, and enhanced HCC cell autophagy.
[CONCLUSIONS] Olaparib targeted UBD to promote autophagy in HCC by inhibiting Gln metabolism pathways.
MeSH Terms
Humans; Animals; Phthalazines; Autophagy; Carcinoma, Hepatocellular; Piperazines; Liver Neoplasms; Mice; Xenograft Model Antitumor Assays; Glutamine; Antineoplastic Agents; Mice, Nude; Mice, Inbred BALB C; Male; Cell Line, Tumor; Down-Regulation; Female; Gene Expression Regulation, Neoplastic
같은 제1저자의 인용 많은 논문 (5)
- Multi-omics profiling reveals that Scissor epithelial cells regulate intrahepatic metastasis of HCC via remodeling the metastatic microenvironment.
- Hesperadin sensitizes gastric cancer cells to cisplatin via NOX1-dependent oxidative stress.
- Integrated Single-Cell Analysis Identifies IL1RAP as a Master Regulator of TAMs and a Prognostic Biomarker in Breast Cancer.
- Discovery of Tetracyclic Derivatives as Highly Potent, Selective, and Bioavailable PKMYT1 Inhibitors for Cancer Therapy.
- Design, synthesis, and evaluation of unsymmetrical trifluoromethyl-containing bisindolylmethane derivatives inducing endoplasmic reticulum stress in human lung adenocarcinoma.